Comments
Dr Reddy’s Laboratories has recalled a single lot of Docetaxel injection vials, used for the treatment of breast cancer.
As per the US health regulator’s enforcement report for the week of January 17, a single lot of 1,051 vials of Docetaxel injection USP, 20 mg/mL was distributed in the US, Uzbekistan and Myanmar. The company has recalled the drug on account of defective container, the report said.
“Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminium seal and/or stopper is removed when the cap is flipped off,” it said.
The vials were manufactured by Dr Reddy’s Laboratories at its Visakhapatnam facility. The voluntary ongoing recall is a class II recall, the regulator said.
As per the USFDA, a class II recall is initiated in a situation, “in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote“.
The company shares were trading 1.23 per cent higher at Rs 2,492.05.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.